CARDIAC INVOLVEMENT IN ASTHMA
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Asthma is one of the most common chronic respiratory diseases in children, and its systemic effects are increasingly recognized. Beyond airway inflammation and bronchoconstriction, pediatric asthma has been linked to cardiovascular alterations that may remain clinically silent. Recurrent hypoxemic episodes, chronic systemic inflammation, and autonomic imbalance impose additional stress on the developing heart, potentially leading to subclinical ventricular dysfunction. Echocardiographic studies, including tissue Doppler imaging and two- and three-dimensional speckle-tracking echocardiography, have demonstrated impaired right and left ventricular performance in children with asthma, even when conventional parameters remain normal. Right ventricular diastolic dysfunction, reduced strain values, and subtle left ventricular abnormalities such as impaired relaxation and decreased global longitudinal strain have all been described. These findings suggest that cardiac involvement is more common than previously appreciated and can be detected only with sensitive imaging modalities. Importantly, such cardiovascular alterations, although frequently subclinical, may have long-term implications for growth, exercise capacity, and overall quality of life in pediatric patients. Pharmacological treatment also carries relevance for cardiovascular safety. Short-acting β2-agonists (SABAs), while central to acute symptom control, have been associated with transient tachycardia and rare episodes of supraventricular tachycardia in children. Although the overall safety profile of SABAs is favorable, awareness of these rare adverse events is important, particularly in patients with pre-existing vulnerability or frequent exacerbations. Clinical manifestations are often subtle, reinforcing the importance of careful cardiovascular evaluation in pediatric asthma populations. Current guidelines recommend avoiding SABA monotherapy and favor combination therapy with inhaled corticosteroids, which may also mitigate cardiovascular risks related to overuse. Furthermore, systematic follow-up with advanced imaging techniques may improve early detection and guide tailored interventions. Multidisciplinary management, integrating pediatric pulmonology and cardiology, is essential for early detection, appropriate follow-up, and long-term outcome optimization. Collectively, available pediatric evidence underscores that asthma is a systemic disease with implications for cardiovascular development, and careful clinical vigilance is required to prevent overlooked cardiac involvement.Keywords: Asthma; Cardiac involvement; Echocardiography
Fields of Study & Subjects
Asthma and respiratory diseases
Cardiovascular Function and Risk Factors
Cardiovascular Effects of Exercise
Publication details
- Journal / source
- Turkiye Klinikleri eBooks
- Pages
- 369–374
- Publication date
- 1 January 2026
- Language
- EN
- Document type
- Book chapter